Macerich Co (MAC) stock
MACNYSEReal Estate Investment TrustsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30116% above fair value
$25.38−0.24 (-0.94%)
Close on Nov 11, 2026Market cap $7.20BP/E –Yield 2.68%
Macerich EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Macerich's EPS for the twelve months ending Sep 30, 2026 was -$0.37. For fiscal 2025 it was -$0.78. The highest annual figure on record is $10.45 in fiscal 2014.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$0.78 | – |
| FY2024 | Dec 31, 2024 | -$0.88 | – |
| FY2023 | Dec 31, 2023 | -$1.28 | – |
| FY2022 | Dec 31, 2022 | -$0.31 | -542.9% |
| FY2021 | Dec 31, 2021 | $0.07 | – |
| FY2020 | Dec 31, 2020 | -$1.58 | -332.4% |
| FY2019 | Dec 31, 2019 | $0.68 | +61.9% |
| FY2018 | Dec 31, 2018 | $0.42 | -58.8% |
| FY2017 | Dec 31, 2017 | $1.02 | -71.0% |
| FY2016 | Dec 31, 2016 | $3.52 | +14.3% |
| FY2015 | Dec 31, 2015 | $3.08 | -70.5% |
| FY2014 | Dec 31, 2014 | $10.45 | +248.3% |
| FY2013 | Dec 31, 2013 | $3.00 | +19.5% |
| FY2012 | Dec 31, 2012 | $2.51 | +112.7% |
| FY2011 | Dec 31, 2011 | $1.18 | +521.1% |
| FY2010 | Dec 31, 2010 | $0.19 | -86.9% |
| FY2009 | Dec 31, 2009 | $1.45 | -33.2% |
| FY2008 | Dec 31, 2008 | $2.17 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$0.06 | – |
| Q2 FY2026 | Jun 30, 2026 | -$0.10 | – |
| Q1 FY2026 | Mar 31, 2026 | -$0.14 | – |
| Q4 FY2025 | Dec 31, 2025 | -$0.07 | – |
| Q3 FY2025 | Sep 30, 2025 | -$0.34 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.16 | -113.8% |
| Q1 FY2025 | Mar 31, 2025 | -$0.20 | – |
| Q4 FY2024 | Dec 31, 2024 | -$0.89 | -406.9% |
| Q3 FY2024 | Sep 30, 2024 | -$0.50 | – |
| Q2 FY2024 | Jun 30, 2024 | $1.16 | – |
| Q1 FY2024 | Mar 31, 2024 | -$0.59 | – |
| Q4 FY2023 | Dec 31, 2023 | $0.29 | +2800.0% |
| Q3 FY2023 | Sep 30, 2023 | -$1.22 | – |
| Q2 FY2023 | Jun 30, 2023 | -$0.07 | – |
| Q1 FY2023 | Mar 31, 2023 | -$0.27 | – |
| Q4 FY2022 | Dec 31, 2022 | $0.01 | -98.0% |
| Q3 FY2022 | Sep 30, 2022 | -$0.07 | – |
| Q2 FY2022 | Jun 30, 2022 | -$0.07 | – |
| Q1 FY2022 | Mar 31, 2022 | -$0.17 | – |
| Q3 FY2021 | Sep 30, 2021 | $0.50 | – |
| Q2 FY2021 | Jun 30, 2021 | -$0.06 | – |
| Q1 FY2021 | Mar 31, 2021 | -$0.40 | -900.0% |
| Q4 FY2020 | Dec 31, 2020 | -$1.27 | -768.4% |
| Q3 FY2020 | Sep 30, 2020 | -$0.15 | -145.5% |
| Q2 FY2020 | Jun 30, 2020 | -$0.18 | -263.6% |
| Q1 FY2020 | Mar 31, 2020 | $0.05 | 0.0% |
| Q4 FY2019 | Dec 31, 2019 | $0.19 | +137.5% |
| Q3 FY2019 | Sep 30, 2019 | $0.33 | -36.5% |
| Q2 FY2019 | Jun 30, 2019 | $0.11 | +120.0% |
| Q1 FY2019 | Mar 31, 2019 | $0.05 | – |
| Q4 FY2018 | Dec 31, 2018 | $0.08 | -65.2% |
| Q3 FY2018 | Sep 30, 2018 | $0.52 | +333.3% |
| Q2 FY2018 | Jun 30, 2018 | $0.05 | -73.7% |
| Q1 FY2018 | Mar 31, 2018 | -$0.24 | -150.0% |
| Q4 FY2017 | Dec 31, 2017 | $0.23 | -11.5% |
| Q3 FY2017 | Sep 30, 2017 | $0.12 | – |
| Q2 FY2017 | Jun 30, 2017 | $0.19 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.48 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.26 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?